Results 161 to 170 of about 38,476 (212)

Idarucizumab Reversal in Subdural Hemorrhage: A Single-Center Experience. [PDF]

Life (Basel)
Mrvar Brečko A, Simerl Jožef M, Trebše A, Zupan M, Velnar T, Frol S.   +5 more
europepmc   +1 more source

Dabigatran Challenges Warfarin’s Superiority for Stroke Prevention in Atrial Fibrillation [PDF]

, 2010
Neil Schwartz, Gregory W. Albers
openalex   +1 more source

Echocardiographic hemodynamics correlate with differences in DOAC-specific bleeding and stroke rates in non-valvular atrial fibrillation. [PDF]

BMC Cardiovasc Disord
O'Shea MP, Yusuf A, Habib E, Ravi S, Karikalan SA, Chao CJ, Ashraf H, Agasthi P, Newton S, Scott RL, Barry T, Ayoub C, Arsanjani R, Masry HE.   +13 more
europepmc   +1 more source

Oral anticoagulation for adults with atrial fibrillation or venous thromboembolism. [PDF]

Aust Prescr
Chin PK, Doogue MP.
europepmc   +1 more source

Balancing Bleeding and Thrombosis in Dental Management of Patients on Novel Oral Anticoagulants: A Narrative Evidence Synthesis. [PDF]

Cureus
Choudhary RS, Kumar N, Dubey M, Sarat Ravi Kiran B.   +3 more
europepmc   +1 more source

The Impact of Direct Oral Anticoagulants vs. Warfarin on Stroke Prevention in Elderly Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Majid S, Rangachari B, Okata D, Kyaw O, Mahmood H, Khan S, Abid M.   +6 more
europepmc   +1 more source

PCV15 COST-EFFECTIVENESS ANALYSIS OF DABIGATRAN ETEXILATE VERSUS ENOXAPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL KNEE REPLACEMENT UNDER THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM PERSPECTIVE

, 2009
RA Fernandes, FF Quintella, V Teich
openalex   +1 more source

Rebound warfarin toxicity presenting with spontaneous hemopericardium in cardiac tamponade: a case report. [PDF]

Int J Emerg Med
Rinzin U, Gurung M.
europepmc   +1 more source

Application Value and Safety Analysis of Warfarin, Rivaroxaban, and Dabigatran Ester in Elderly Patients With Atrial Fibrillation [PDF]

Cheng Chen, Qing Tian, Chong Cheng, Xixin Ji, Mengyun Feng, Huiqun Tan, Qian Zhou   +6 more
openalex   +1 more source

Effect of vepdegestrant, a PROTAC oestrogen receptor degrader, on dabigatran and rosuvastatin pharmacokinetics in healthy participants. [PDF]

Br J Clin Pharmacol
Yang DZ, Zhou L, Winton JA, Matschke KT, Kantaridis C, Doyle K, Lee KC, Chen N, Zhang Y, Tan W.   +9 more
europepmc   +1 more source